26 related articles for article (PubMed ID: 37718518)
1. DNMT3A promotes glioma growth and malignancy via TNF-α/NF-κB signaling pathway.
Su X; Liu J; Tu Z; Ji Q; Li J; Liu F
Transl Cancer Res; 2024 Apr; 13(4):1786-1806. PubMed ID: 38737693
[TBL] [Abstract][Full Text] [Related]
2. Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma.
Zhou Y; Cao Y; Liu W; Wang L; Kuang Y; Zhou Y; Chen Q; Cheng Z; Huang H; Zhang W; Jiang X; Wang B; Ren C
Front Immunol; 2023; 14():1294459. PubMed ID: 38162649
[TBL] [Abstract][Full Text] [Related]
3. Malignant Tumor Purity Reveals the Driven and Prognostic Role of
Lu X; Li C; Xu W; Wu Y; Wang J; Chen S; Zhang H; Huang H; Huang H; Liu W
Front Oncol; 2021; 11():676124. PubMed ID: 34557404
[TBL] [Abstract][Full Text] [Related]
4. The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort.
Huang QR; Jiang Q; Tan JY; Nong RB; Yan J; Yang XW; Mo LG; Ling GY; Deng T; Gong YZ
Front Pharmacol; 2024; 15():1390615. PubMed ID: 38698811
[No Abstract] [Full Text] [Related]
5. Identification of Key Molecular Pathways and Associated Genes as Targets to Overcome Radiotherapy Resistance Using a Combination of Radiotherapy and Immunotherapy in Glioma Patients.
Zhang T; Zhang Q; He X; Lu Y; Shao A; Sun X; Shao Y
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474320
[TBL] [Abstract][Full Text] [Related]
6. Integration of Single-Cell and Bulk RNA-seq Data to Identify the Cancer-Associated Fibroblast Subtypes and Risk Model in Glioma.
Yan X; Gao X; Dong J; Wang F; Jiang X; Hu X; Zhang J; Wang N; Xu L; Liu Z; Hu S; Zhao H
Biochem Genet; 2024 Mar; ():. PubMed ID: 38536568
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analyses of m1A regulator-mediated modification patterns determining prognosis in lower-grade glioma (running title: m1A in LGG).
Lei K; Sheng Y; Luo M; Liu J; Gong C; Lv S; Tu W; Ye M; Wu M; Xiao B; Fang H; Luo H; Liu X; Long X; Zhu X; Huang K; Li J
Heliyon; 2024 Mar; 10(6):e27510. PubMed ID: 38510043
[TBL] [Abstract][Full Text] [Related]
8. Identification of Lower Grade Glioma Antigens Based on Ferroptosis Status for mRNA Vaccine Development.
Zhao Z; Xing N; Guo H; Li J; Sun G
Pharmgenomics Pers Med; 2024; 17():105-123. PubMed ID: 38623558
[TBL] [Abstract][Full Text] [Related]
9. Significance of NotchScore and JAG1 in predicting prognosis and immune response of low-grade glioma.
Shi B; Ge F; Cai L; Yang Y; Guo X; Wu R; Fan Z; Cao B; Wang N; Si Y; Lin X; Dong W; Sun H
Front Immunol; 2023; 14():1247288. PubMed ID: 38022677
[TBL] [Abstract][Full Text] [Related]
10. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
Front Immunol; 2022; 13():899710. PubMed ID: 35677036
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of γ-aminobutyric acidergic synapse-associated signature for lower-grade gliomas.
Jiang H; Sun Z; Li F; Chen Q
Front Immunol; 2022; 13():983569. PubMed ID: 36405708
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
Front Immunol; 2022; 13():933973. PubMed ID: 36045691
[TBL] [Abstract][Full Text] [Related]
13. TGF-β score based on silico analysis can robustly predict prognosis and immunological characteristics in lower-grade glioma: the evidence from multicenter studies.
Zhang W; Yan Z; Zhao F; He Q; Xu H
Recent Pat Anticancer Drug Discov; 2023 Sep; ():. PubMed ID: 37718518
[TBL] [Abstract][Full Text] [Related]
14. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Zhang Q; Hong J
Front Genet; 2020; 11():363. PubMed ID: 32351547
[TBL] [Abstract][Full Text] [Related]
15. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
Xu S; Wang Z; Ye J; Mei S; Zhang J
Front Oncol; 2021; 11():729103. PubMed ID: 34568059
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
